by Stacey Johnson | Nov 27, 2015
To some people, November is now Movember. That is testament to how successful and pervasive this campaign for men’s health – especially prostate cancer – has become. (Blogger Sara Nolte has also chosen to write about prostate cancer during Movember.) Last month the...
by Mark Curtis | Nov 24, 2015
Welcome to your Cell Therapy Deal Review for the month of October. Lion Biotechnologies and Kite Pharma both made deals with the National Institutes of Health (NIH) that significantly expanded their respective pipelines. Kite also announced a research collaboration...
by Hamideh Emrani | Nov 20, 2015
I’ve been blogging about some of the talks that I heard at the recent Till & McCulloch Meetings (TMM) in Toronto, Canada. Maybe you’ve read them (featuring speakers Molly Shoichet and Milica Radisic)? For this blog, I want to take a different focus. TMM is diverse...
by David Kent | Nov 16, 2015
The United Kingdom has begun its foray into using cells derived from human embryonic stem cells (ESCs) in clinical settings. I have to admit I was surprised that following coverage on the BBC and in The Guardian, there was virtually no anti-ESC protesting to be found,...
by Stacey Johnson | Nov 13, 2015
Are you a wannabe astronaut? If you haven’t yet heard the news, NASA is hiring. Think you got the right stuff? The boys from One Direction do and you’ll know this if you have viewed their “NASA” video (over 185 million have clicked!). Now, apart from...
by Holly Wobma | Nov 10, 2015
The last two decades have seen a number of fascinating innovations in biomaterial scaffolds development. This comes from the growing realization that 2D culture of cells can only do so much in terms of mimicking physiological niches of the body. To encourage...
by Hamideh Emrani | Nov 9, 2015
Continuing with the theme of interesting biomaterials-related talks at the recent Till & McCulloch Meetings in Toronto, Canada, was the one delivered by Professor Molly Shoichet from the University of Toronto. Her group focuses on designing polymer scaffolds to...
by Stacey Johnson | Nov 6, 2015
According to the helpful infographic below from Thermo Fisher, genetic engineering has been around since 1831. With the introduction of CRISPR/Cas9 in 2012, genome engineering – or at least CRISPR – seems to be on everyone’s lips. Signals bloggers are no exception....
by Hamideh Emrani | Nov 4, 2015
Among many interesting talks at this year’s Till and McCulloch Meetings in Toronto, Canada, there were a couple related to biomaterials, which I’d like to focus on. In the first talk, professor Milica Radisic, University of Toronto, talked about two recent...
Comments